Financial Advantage, Inc. - BLACKROCK HEALTH SCIENCES TR ownership

BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 59 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Financial Advantage, Inc. ownership history of BLACKROCK HEALTH SCIENCES TR
ValueSharesWeighting
Q3 2022$31,000
-6.1%
8010.0%0.03%
+3.3%
Q2 2022$33,000
-8.3%
8010.0%0.03%
+3.4%
Q1 2022$36,000
-5.3%
8010.0%0.03%
-6.5%
Q4 2021$38,000
-2.6%
801
-3.8%
0.03%
-8.8%
Q3 2021$39,000
-2.5%
8330.0%0.03%0.0%
Q2 2021$40,000
+5.3%
8330.0%0.03%
+3.0%
Q1 2021$38,000
-2.6%
8330.0%0.03%
-8.3%
Q4 2020$39,000
+18.2%
833
+7.8%
0.04%
+16.1%
Q3 2020$33,000
+6.5%
7730.0%0.03%
+34.8%
Q2 2020$31,000
+14.8%
7730.0%0.02%
-4.2%
Q1 2020$27,000
-15.6%
7730.0%0.02%
+9.1%
Q4 2019$32,0000.0%773
-7.6%
0.02%0.0%
Q3 2019$32,0000.0%8370.0%0.02%0.0%
Q2 2019$32,000
-3.0%
8370.0%0.02%
-8.3%
Q1 2019$33,000
+10.0%
8370.0%0.02%
-4.0%
Q4 2018$30,000
+11.1%
837
+11.7%
0.02%
+13.6%
Q3 2017$27,000
-3.6%
7490.0%0.02%
-15.4%
Q3 2015$28,000
-12.5%
7490.0%0.03%
-16.1%
Q2 2015$32,000
-48.4%
749
-48.3%
0.03%
-43.6%
Q1 2015$62,0000.0%1,4500.0%0.06%
-3.5%
Q4 2014$62,000
+10.7%
1,4500.0%0.06%
+7.5%
Q3 2014$56,000
+5.7%
1,4500.0%0.05%
+1.9%
Q2 2014$53,000
-1.9%
1,4500.0%0.05%
-1.9%
Q1 2014$54,000
+5.9%
1,4500.0%0.05%
+23.3%
Q4 2013$51,000
+8.5%
1,4500.0%0.04%
+4.9%
Q3 2013$47,000
+4.4%
1,4500.0%0.04%
+5.1%
Q2 2013$45,0001,4500.04%
Other shareholders
BLACKROCK HEALTH SCIENCES TR shareholders Q2 2021
NameSharesValueWeighting ↓
Nova R Wealth, Inc. 410,736$16,692,29411.18%
Alterity Financial Group, LLC 12,484$507,3300.73%
Cornerstone Advisory, LLC 88,503$3,596,7590.63%
Owen LaRue, LLC 13,117$528,3370.56%
Semus Wealth Partners LLC 13,170$535,2290.49%
PRIMORIS WEALTH ADVISORS, LLC 7,984$324,4890.36%
CORRADO ADVISORS, LLC 9,285$377,3430.26%
Elequin Capital, LP 9,231$375,1480.19%
Founders Financial Alliance, LLC 10,617$431,4890.17%
Diversified, LLC 12,412$504,4320.13%
View complete list of BLACKROCK HEALTH SCIENCES TR shareholders